Results 21 to 30 of about 1,827,024 (396)
Techniques for the Detection of Sickle Cell Disease: A Review
Sickle cell disease (SCD) is a widespread disease caused by a mutation in the beta-globin gene that leads to the production of abnormal hemoglobin called hemoglobin S.
W. Arishi, H. Alhadrami, M. Zourob
semanticscholar +1 more source
Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin.
The issue of treating sickle cell disease with drugs that increase hemoglobin oxygen affinity has come to the fore with the FDA approval in 2019 of voxelotor, the only anti-sickling drug approved since hydroxyurea in 1998.
E. Henry+11 more
semanticscholar +1 more source
HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription
Background HIV-1 transcription activator protein Tat is phosphorylated in vitro by CDK2 and DNA-PK on Ser-16 residue and by PKR on Tat Ser-46 residue. Here we analyzed Tat phosphorylation in cultured cells and its functionality. Results Mass spectrometry
Andrey Ivanov+9 more
doaj +1 more source
Mortality in sickle cell disease. Life expectancy and risk factors for early death.
BACKGROUND Information on life expectancy and risk factors for early death among patients with sickle cell disease (sickle cell anemia, sickle cell-hemoglobin C disease, and the sickle cell-beta-thalassemias) is needed to counsel patients, target therapy,
O. Platt+6 more
semanticscholar +1 more source
Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. [PDF]
BACKGROUND: People affected with sickle cell disease are at high risk of infection from Haemophilus influenzae type b. Before the implementation of Haemophilus influenzae type b conjugate vaccination in high-income countries, this was responsible for a ...
Allali, Slimane+4 more
core +2 more sources
Protein Phosphatase-1 Regulates Expression of Neuregulin-1
Protein phosphatase 1 (PP1), a cellular serine/threonine phosphatase, is targeted to cellular promoters by its major regulatory subunits, PP1 nuclear targeting subunit, nuclear inhibitor of PP1 (NIPP1) and RepoMan.
Tatiana Ammosova+7 more
doaj +1 more source
Successful orthotopic liver transplantation in an adult patient with sickle cell disease and review of the literature [PDF]
Sickle cell disease can lead to hepatic complications ranging from acute hepatic crises to chronic liver disease including intrahepatic cholestasis, and iron overload.
Blinder, Morey A.+7 more
core +2 more sources
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease.
BACKGROUND Sickle cell disease is characterized by hemolytic anemia, pain, and progressive organ damage. A high level of erythrocyte fetal hemoglobin (HbF) comprising α- and γ-globins may ameliorate these manifestations by mitigating sickle hemoglobin ...
Erica B Esrick+24 more
semanticscholar +1 more source
Red cell transfusion and alloimmunization in sickle cell disease
Red cell transfusion remains a critical component of care for acute and chronic complications of sickle cell disease. Randomized clinical trials demonstrated the benefits of transfusion therapy for prevention of primary and secondary strokes and ...
G. Linder, S. Chou
semanticscholar +1 more source
The risk of stroke in children with sickle cell disease (SCD) is detected by abnormal intracranial arterial time-averaged mean of maximum velocities (TAMVs ≥200 cm/s).
Françoise Bernaudin+8 more
doaj +1 more source